Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

8,518 total articles

Quanta Services: Buy the Grid Play Powering the AI Buildout

Quanta Services: Buy the Grid Play Powering the AI Buildout

Quanta Services sits at the physical intersection of AI demand and electric infrastructure. Backlog, free cash flow and a new buyback create a constructive setup despite a premium multiple. This is a swing trade: buy the pullback around current levels with a mid-term horizon while watching execution and margin trends closely.

Autodesk Is an AI-Era Value Play — Buy the Dip, Back the Execution

Autodesk Is an AI-Era Value Play — Buy the Dip, Back the Execution

Autodesk shares trade well below last year's highs despite strong cash generation, a recent strategic M&A bolt-on and early signs management is leaning into AI. With market cap ~ $46.1B, free cash flow of $2.73B and an EV/EBITDA of ~17.2, the risk/reward favors a long entry now for traders who want to back a recovery and AI re-rating over the next …

AMD Into Earnings: A Measured Long on a Pullback Before 8/04 Print

AMD Into Earnings: A Measured Long on a Pullback Before 8/04 Print

Advanced Micro Devices (AMD) faces a binary August 4 earnings print. The stock is trading well below its June highs after a semiconductor sector pullback. With a market cap near $808B, chunky free cash flow and aggressive revenue growth targets priced into the shares, this trade favors disciplined, size-managed long exposure on a pullback to suppor…

Buy the Dip: Waste Management Looks Worth Owning After Pullback

Buy the Dip: Waste Management Looks Worth Owning After Pullback

Waste Management (WM) recently underperformed but still trades inside a constructive range with solid fundamentals: ~$96B market cap, $3.29B in free cash flow, and a 23-year dividend growth streak. Pair those fundamentals with a fresh $3B buyback, AI-driven efficiency gains, and a resilient end-market and you have an asymmetric trade. I recommend a…

Buy the Next-Gen AI Dip: Nvidia’s Stack Is Poised for a Re-Rate

Buy the Next-Gen AI Dip: Nvidia’s Stack Is Poised for a Re-Rate

Nvidia is trading below recent highs after a sector-wide pullback. Fundamentals remain strong: a $4.985T market cap, 81.7% ROE, $119B free cash flow and an EPS of $6.59. We lay out a mid-term long trade (45 trading days) with an entry at $200.00, stop at $188.00 and a target at $260.00, backed by product catalysts around HBM4 and next-generation ar…

Yext: Scout-Led Re-Acceleration Could Make $YEXT a Tactical Long

Yext: Scout-Led Re-Acceleration Could Make $YEXT a Tactical Long

Yext is a sub-$1B market-cap SaaS name where product evolution around a 'Scout' intelligent search layer could re-risk growth while valuation already discounts a muted outcome. The company generates positive free cash flow ($53M last reported), carries an enterprise value of roughly $591M and trades around $5.35. This trade targets a mid-term rebou…

Buy STIM on Growth and Cheap P/S; Watch Margins and Cash Flow

Buy STIM on Growth and Cheap P/S; Watch Margins and Cash Flow

Neuronetics (STIM) is a small-cap medical technology name with accelerating revenue drivers in transcranial magnetic stimulation (TMS) and an attractive price-to-sales of 0.74. The stock trades near $1.62 with an enterprise value of roughly $160.8M, leaving room for a re-rate if adoption and reimbursement continue to improve. However, negative marg…

IBM After the Z Shock: A Defensive Long With a Tactical Entry

IBM After the Z Shock: A Defensive Long With a Tactical Entry

IBM plunged after a surprise weakness in its Z mainframe business, but the stock now trades near the 52-week low with a 3%+ yield, healthy free cash flow and an attractive risk/reward for long-term holders who can stomach near-term execution risk. This trade idea lays out an entry at $212.66, a stop at $198.00 and a 180-trading-day target of $280.0…

ASML: Buy into the AI Capex Cycle — A 180-Day Trade Plan

ASML: Buy into the AI Capex Cycle — A 180-Day Trade Plan

ASML sits at the center of the AI infrastructure build-out. Recent results show accelerating revenue and a 2026 guide lift to €43-45B, while management is committing to a 30% capacity increase now (with another potential 30% in 2028). That combination of structural demand and supply-constrained positioning supports a long trade with a 180-trading-d…

Assembly Biosciences: Gilead Partnership and Clinical Optionality Make ASMB a Leverage Play on Next-Gen Antivirals

Assembly Biosciences: Gilead Partnership and Clinical Optionality Make ASMB a Leverage Play on Next-Gen Antivirals

Assembly Biosciences (ASMB) offers a way to play a concentrated biotech bet with a strong strategic partner. With positive Phase 1b readouts for two long-acting helicase-primase inhibitors, a Gilead collaboration, and cash into 2028, the stock ($26.81) already discounts some risk but not all of the upside from Phase 2 starts and potential deal flow…

Tactical Long on RDW: Buy the Dilution Dip After a 65% Retreat

Tactical Long on RDW: Buy the Dilution Dip After a 65% Retreat

Redwire (RDW) has been punished since its late-May peak as an announced $500M at-the-market offering and sector rotation into SpaceX hammered the stock. At roughly $8.50 and a $2.02B market cap, the company still shows strong top-line momentum and a sizable backlog, while balance-sheet leverage is manageable. This is a tactical long with tight risk…

Acco Brands: Cheap, Cash-Generating, and Set Up for a Controlled Rebound

Acco Brands: Cheap, Cash-Generating, and Set Up for a Controlled Rebound

<p>Acco Brands (ACCO) trades at bargain multiples, throws off free cash flow of roughly $49M, and yields over 7% — metrics that argue for a constructive long trade on weakness. The company is small-cap, levered, and exposed to cyclical end markets, so position sizing and a clear stop are essential. This idea targets a measured rebound toward prior …

BJ's Restaurants: Appetite for More After a Strong Breakout

BJ's Restaurants: Appetite for More After a Strong Breakout

BJ's Restaurants (BJRI) has ripped to fresh 52-week highs on heavy volume, but the move is backed by solid profitability, healthy free cash flow and a conservative balance sheet. The stock looks actionable on a mid-term (45 trading days) swing with a clear entry, stop and target that balances momentum with valuation discipline.